Proverum - Gilde Healthcare


Dublin, Ireland
Medical device to treat Benign Prostate Hyperplasia
Since: 2022

Proverum is an Irish medical device company founded in 2016 as a spin-off from Trinity College Dublin. The company is developing a novel treatment solution for patients with symptomatic BPH designed to be safely and effectively performed in a doctor’s office setting in a simple procedure under local anaesthesia. Gilde invested in 2022 to support the Company’s clinical programme and other operating activities in pursuit of regulatory approval for the ProVee system in Europe and the US.

More Proverum news

Gilde Healthcare company ProVerum Announces Completion of Enrollment for the ProVIDE Clinical Study for BPH and First-use of its New Flexible, Steerable Delivery System

First Enrolment in the ProVIDE Clinical Study for BPH Treatment